1. Home
  2. IKT vs KOPN Comparison

IKT vs KOPN Comparison

Compare IKT & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • KOPN
  • Stock Information
  • Founded
  • IKT 2008
  • KOPN 1984
  • Country
  • IKT United States
  • KOPN United States
  • Employees
  • IKT N/A
  • KOPN N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • IKT Health Care
  • KOPN Technology
  • Exchange
  • IKT Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • IKT 168.0M
  • KOPN 138.4M
  • IPO Year
  • IKT 2020
  • KOPN 1992
  • Fundamental
  • Price
  • IKT $2.00
  • KOPN $1.43
  • Analyst Decision
  • IKT Buy
  • KOPN Strong Buy
  • Analyst Count
  • IKT 2
  • KOPN 4
  • Target Price
  • IKT $8.00
  • KOPN $2.56
  • AVG Volume (30 Days)
  • IKT 113.6K
  • KOPN 2.2M
  • Earning Date
  • IKT 05-14-2025
  • KOPN 05-16-2025
  • Dividend Yield
  • IKT N/A
  • KOPN N/A
  • EPS Growth
  • IKT N/A
  • KOPN N/A
  • EPS
  • IKT N/A
  • KOPN N/A
  • Revenue
  • IKT N/A
  • KOPN $50,335,167.00
  • Revenue This Year
  • IKT N/A
  • KOPN $8.75
  • Revenue Next Year
  • IKT N/A
  • KOPN $24.15
  • P/E Ratio
  • IKT N/A
  • KOPN N/A
  • Revenue Growth
  • IKT N/A
  • KOPN 24.61
  • 52 Week Low
  • IKT $1.12
  • KOPN $0.56
  • 52 Week High
  • IKT $4.20
  • KOPN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • IKT 46.57
  • KOPN 66.87
  • Support Level
  • IKT $1.78
  • KOPN $1.24
  • Resistance Level
  • IKT $2.13
  • KOPN $1.38
  • Average True Range (ATR)
  • IKT 0.16
  • KOPN 0.09
  • MACD
  • IKT -0.01
  • KOPN 0.04
  • Stochastic Oscillator
  • IKT 37.61
  • KOPN 98.09

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: